FEI Consultation Process On NSAIDs Begins
On the occasion of its Executive Board (EB) meeting held at the FEI Headquarters today, 9 March, the FEI announced further steps in relation to the debate on in-competition use of a limited number of non-steroidal anti-inflammatory drugs (NSAIDs) under strictly prescribed limits and set the relevant timeline.
A central point in the debate will be the FEI Congress on NSAIDs Usage and Medication in the Equine Athlete which will be held in Lausanne in August.
To lead the debate, the EB appointed an FEI Congress Committee chaired by 1st Vice President Sven Holmberg and composed of Chris Hodson (2nd Vice President), John McEwen (Chairman of FEI Veterinary Committee), Graeme Cooke (FEI Veterinary Director), Dr Yves Rossier, and Prof. Leo Jeffcott as members.
The composition of the FEI List Group is being finalised and will be announced shortly.
The following timeline has been established:
FEI General Assembly votes on policy
To facilitate the debate, the FEI will set up in the coming weeks a virtual platform open to the global audience. National Federations, riders, trainers, officials, event organisers, veterinarians, the media as well as the general public will be able to access the science currently available and will be encouraged to submit their contributions to the debate.
Further details on the launch of the online platform and the logistics of the Congress will be announced in due course.
Copyright © 1990-2018 Red Bay Group, LLC